A cDNA-dependent scintillation proximity assay for quantifying apolipoprotein A-I

Area of Science:

• Biochemistry
• Molecular Biology
• Assay Development

Background:

• Quantifying apolipoprotein A-I (apoA-I) is crucial for understanding lipid metabolism and cardiovascular health.
• Existing methods for apoA-I quantification can be labor-intensive or require specialized equipment.

Purpose of the Study:

• To develop a novel, sensitive, and reliable cDNA-dependent scintillation proximity assay (SPA) for quantifying rabbit apolipoprotein A-I (apoA-I).
• To validate the assay's performance across different biological matrices and compare it with established quantification techniques.

Main Methods:

• A cDNA-dependent scintillation proximity assay (SPA) was established using a classic radioimmunoassay scheme.
• Radiolabeled apoA-I was synthesized via in vitro transcription and translation using tritiated leucine.
• Assay conditions were optimized for quantifying unlabeled apoA-I from 0.2 to 4 nanograms.

Main Results:

• The developed SPA demonstrated high precision with intra- and interassay coefficients of variation of 5% and 10%, respectively.
• Parallel titration curves were observed for purified apoA-I, apoA-I in cell conditioned media, and apoA-I in plasma.
• Quantification of apoA-I was unaffected by the presence of antibodies against other apolipoproteins, indicating assay specificity.

Conclusions:

• The cDNA-dependent SPA provides a sensitive and robust method for quantifying rabbit apoA-I in diverse biological samples.
• The assay's results strongly correlated with Western blotting and electroimmunodiffusion, validating its utility.
• This approach facilitates the rapid development of SPAs for other proteins using readily available full-length cDNAs.